Sou Hu Cai Jing·2025-06-14 17:26Core Viewpoint - *ST Changyao has completed the recruitment and selection of restructuring investors and is awaiting approval from the CSRC and the Supreme Court to enter the formal restructuring phase [1][2] Group 1: Stock Performance - As of June 13, 2025, *ST Changyao closed at 4.51 yuan, up 3.44% from the previous week's 4.36 yuan [1] - The stock reached a weekly high of 4.72 yuan on June 12 and a low of 4.38 yuan on June 9 [1] - The current total market capitalization is 1.58 billion yuan, ranking 67th in the traditional Chinese medicine sector and 5075th in the A-share market [1] Group 2: Restructuring Progress - The restructuring investment agreements have been signed with several investors, including Jia Dao Bo Wen and Hao Wei Biological, as well as financial investors such as Da Han Fund and others [1] - The final restructuring plan has not yet been determined, and the conversion date will be based on the restructuring plan [2] - The industrial investor has not requested asset injection into the company at this stage [2]